MYOZYME 50 mg, powder for concentrate for infusion 10 bottles of 20 ml
Active ingredients: Alglucosidase alfa
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Powder for concentrate for infusion10 bottles of 20 mlintraveineuse
Supply disruption
Package details
Original BDPM fields are shown in French.
- Official name
- MYOZYME 50 mg, poudre pour solution à diluer pour perfusion
- Pharmaceutical form
- poudre pour solution à diluer pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 10 flacon(s) en verre de 20 ml
- Marketing authorisation holder
- SANOFI (PAYS-BAS)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 9 Jan 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61065137CIP73024701CIP133400930247013Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ALGLUCOSIDASE ALFApoudre | 50 mg · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.